Virtus Fund Advisers’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $56.5K | Buy |
1,022
+35
| +4% | +$1.94K | 0.18% | 58 |
|
|
2024
Q3 | $58.9K | Hold |
987
| – | – | 0.24% | 53 |
|
|
2024
Q2 | $62.9K | Buy |
987
+117
| +13% | +$7.45K | 0.25% | 46 |
|
|
2024
Q1 | $60.1K | Hold |
870
| – | – | 0.21% | 54 |
|
|
2023
Q4 | $48K | Hold |
870
| – | – | 0.3% | 50 |
|
|
2023
Q3 | $50.5K | Buy |
+870
| New | +$50.5K | 0.36% | 44 |
|
|
2017
Q3 | – | Sell |
-6,188
| Closed | -$295K | – | 487 |
|
|
2017
Q2 | $295K | Sell |
6,188
-184
| -3% | -$8.77K | ﹤0.01% | 371 |
|
|
2017
Q1 | $315K | Sell |
6,372
-411
| -6% | -$20.3K | ﹤0.01% | 377 |
|
|
2016
Q4 | $411K | Hold |
6,783
| – | – | ﹤0.01% | 356 |
|
|
2016
Q3 | $450K | Buy |
+6,783
| New | +$450K | ﹤0.01% | 345 |
|
|
2014
Q3 | – | Sell |
-586
| Closed | -$20K | – | 1195 |
|
|
2014
Q2 | $20K | Buy |
+586
| New | +$20K | ﹤0.01% | 2432 |
|